Form 4: Marpai CFO Steve Johnson Boosts Stake with Significant RSU Grant
Insider Transaction Report
Marpai, Inc.'s Chief Financial Officer, Steve Johnson, has acquired 150,000 shares of Class A Common Stock through a Restricted Stock Unit (RSU) grant, increasing his total beneficial ownership to 623,061 shares.
Summary
- Marpai, Inc. (MRAI) Chief Financial Officer, Steve Johnson, acquired 150,000 shares of Class A Common Stock.
- The acquisition occurred on June 9, 2025, as a Restricted Stock Unit (RSU) grant at a price of $0 per share.
- Following this transaction, Mr. Johnson's direct beneficial ownership of Marpai's Class A Common Stock increased to 623,061 shares.
- The RSUs vest according to a schedule: 50,000 RSUs vested immediately on the grant date, 50,000 RSUs will vest on the first anniversary of the grant, and the remaining 50,000 RSUs will vest on the second anniversary of the grant.
Sentiment
Score: 7
Explanation: The acquisition of shares by a key executive through an RSU grant is generally viewed positively as it aligns management's interests with shareholders and indicates confidence in the company's future. It's a standard compensation event, not an open market purchase, hence not a 'strong buy' signal, but still positive.
Positives
- The acquisition of 150,000 shares by the Chief Financial Officer, Steve Johnson, aligns his interests with those of shareholders, indicating confidence in the company's future performance.
- The grant of Restricted Stock Units (RSUs) is a common form of executive compensation that incentivizes long-term commitment and performance.
Future Outlook
The RSU grant includes a vesting schedule over two years, indicating a future alignment of the CFO's interests with the company's long-term performance and retention of key management.
Industry Context
The grant of Restricted Stock Units (RSUs) to a Chief Financial Officer is a standard practice in executive compensation across various industries, aiming to incentivize long-term performance and retain key talent. This aligns Marpai, Inc. with common corporate governance and compensation strategies.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice across publicly traded companies, including those in the healthcare technology and insurance sectors where Marpai operates.
- The vesting schedule, with immediate and staggered vesting over two years, is typical for RSU grants, balancing immediate reward with long-term retention incentives.
- While specific comparable companies or projects are not detailed in this Form 4, the structure of this compensation aligns with general industry benchmarks for executive equity awards.
Related Party Transactions
- The RSU grant to Steve Johnson, the Chief Financial Officer, constitutes a related party transaction as it involves compensation from the company to a key executive.
Stakeholder Impact
- Shareholders: Positive impact as the CFO's increased equity stake aligns his financial interests with the company's long-term performance and shareholder value creation.
- Employees: May signal stability in executive leadership and a commitment to retaining key talent.
Next Steps
- Vesting of 50,000 RSUs on the first anniversary of the grant (June 9, 2026).
- Vesting of 50,000 RSUs on the second anniversary of the grant (June 9, 2027).
Key Dates
| Date | Description |
|---|---|
| 06/09/2025 | Date of RSU grant transaction for 150,000 shares. |
| 06/09/2025 | Vesting date for 50,000 RSUs (immediate vesting). |
| 06/12/2025 | Date the Form 4 was signed by Steve Johnson. |
| 06/09/2026 | Expected vesting date for 50,000 RSUs (first anniversary of grant). |
| 06/09/2027 | Expected vesting date for 50,000 RSUs (second anniversary of grant). |
Recommendation
holdKeywords
Marpai, MRAI, SEC Form 4, Restricted Stock Units, RSU grant, insider ownership, executive compensation, beneficial ownership, Chief Financial Officer, Steve Johnson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.